Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Scandinavian Journal of Gastroenterology|March 15, 2005
Lack of association of the CD14 promoter polymorphism--159C/T with Caucasian inflammatory bowel diseaseKirsten E Peters, Nathan J O'Callaghan, Juleen A CavanaughInternal Medicine Journal|January 15, 2024
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase IITimothy M E Davis, Kirsten E Peters, Wendy DavisThe Journal of Clinical Endocrinology and Metabolism|February 25, 2012
Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes StudyTimothy M E Davis, Kirsten E Peters, David G Bruce, et al.Internal Medicine Journal|September 4, 2023
Serum vitamin B12, distal symmetrical polyneuropathy and anaemia in type 2 diabetes: the Fremantle Diabetes Study Phase 2Timothy M E Davis, Stephen A P Chubb, Kirsten E Peters, et al.Plos One|September 11, 2013
The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes StudyKirsten E Peters, S A Paul Chubb, Wendy A Davis, et al.Cardiovascular Diabetology|October 8, 2016
Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes StudyS A Paul Chubb, Wendy A Davis, Kirsten E Peters, et al.Clinical Endocrinology|January 28, 2020
Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase IIKirsten E Peters, Stephen A Paul Chubb, David G Bruce, et al.Diabetes Research and Clinical Practice|July 4, 2018
The relationship between circulating adiponectin, ADIPOQ variants and incident cardiovascular disease in type 2 diabetes: The Fremantle Diabetes StudyKirsten E Peters, Wendy A Davis, John Beilby, et al.Acta Diabetologica|September 9, 2022
The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase IIS A Paul Chubb, Kirsten E Peters, David G Bruce, et al.Journal of Diabetes and Its Complications|November 1, 2019
Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase IIKirsten E Peters, Wendy A Davis, Jun Ito, et al.Pageof 3